Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents

Allergy & Rhinology

Case Report

Phuong Daniels¹  Haig Tcheurekdjian²  Neha Sanan³  Jason Schend³  Robert Hostoffer⁴ 

[1] Department of Pediatrics, Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania;Department of Pediatrics, Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania;Allergy/Immunology Associates Inc., Mayfield Heights, Ohio;Department of Pulmonary/Critical Care, University Hospitals, Cleveland Medical Center, Cleveland, Ohio;Department of Pulmonary/Critical Care, University Hospitals, Cleveland Medical Center, Cleveland, Ohio;Department of Pediatrics, Lake Erie College of Osteopathic Medicine, Erie, Pennsylvania;Allergy/Immunology Associates Inc., Mayfield Heights, Ohio;

关键词: COVID-19;    immunodeficiency;    rituximab;    SARS-CoV-2;    chemotherapy;   

DOI  :  10.1177/2152656720978764

来源: Sage Journals

【 授权许可】

CC BY-NC   
© The Author(s) 2020

【 图 表 】

Figure 4.

Figure 15.

Figure 1.